Replies to post #236018 on Biotech Values

[vinmantoo]

The ASH poster has a couple of updates:

The last we knew they were going to increase the dosing from 8g to 12g. Now they are dosing at 18mg and the response of the 12 mg patients isn't available.

Thanks Jbog for beating me to it. Let me add that this poster deals with TTI-622 only. I believe the data for TRIL's TTI-621 and its dosage escalation should come later in this ASH meeting, maybe monday.